EEI-BIOTECHFINANCES Eléments Essentiels d'Information / Essential Elements of Information
Thursday, June 20th 2019 at 8:10pm UTC BEDFORD, Mass.–(BUSINESS WIRE)– Novanta Inc. (Nasdaq: NOVT) (the « Company »), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 19th Annual “New Ideas” Summer Conference on …
Plus »Aurinia Reminds Shareholders to Vote the YELLOW Proxy Prior to June 24 Deadline
Friday, June 21st 2019 at 10:30am UTC Shareholders can vote the YELLOW proxy even if they previously voted on the green proxy Proxy voting deadline is 10:00 AM Mountain Time on Monday, June 24th VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today reminded …
Plus »Abzena Expands Leadership Team With Andrew Kraus as Chief Technology Officer and Philip Payne as Chief Commercial Officer
Friday, June 21st 2019 at 9:19am UTC SAN DIEGO–(BUSINESS WIRE)– Abzena, the leading global biologics and ADC target partner research organization, announced it has appointed Andrew Kraus as Chief Technology Officer (CTO) and Philip Payne as Chief Commercial Officer (CCO). As CTO Mr. Kraus will implement advanced technology solutions to …
Plus »Leading Independent Proxy Advisors Recommend Aurinia Shareholders Vote the YELLOW Proxy Card FOR All of Aurinia’s Director Nominees
Wednesday, June 19th 2019 at 10:30am UTC ISS and Glass Lewis Recommend Aurinia Shareholders Not Support ILJIN’s Nominees Highlight Aurinia’s Strong Track Record of Shareholder Value Creation Note ILJIN has Failed to Make a Compelling Case for Change VICTORIA, British Columbia–(BUSINESS WIRE)– Leading independent proxy advisory firms Institutional Shareholder Services …
Plus »Zymeworks Announces Pricing of $175.0 Million Public Offering
Thursday, June 20th 2019 at 1:19am UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE/TSX:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics (the “Company”), announced today the pricing of its previously-announced underwritten public offering (the “Offering”) of 5,555,556 common shares and, to a certain investor, pre-funded warrants to purchase up to …
Plus »Medison Issues Open Letter to Knight Therapeutics Shareholders Urging Jonathan Goodman to Build Real Business during the Grace Period Knight Received
Wednesday, June 19th 2019 at 1:34pm UTC PETACH TIKVA, Israel–(BUSINESS WIRE)– Medison Biotech (1995) Ltd. (“Medison”), which together with its affiliates owns more than 10.4 million shares or 7.3% of Knight Therapeutics, Inc. (TSX:GUD) (“Knight” or the “Company”), today issued the following open letter from Medison CEO Meir Jakobsohn on …
Plus »30-Year Life Sciences Veteran Don Enns Joins Microbiome Insights Board of Directors
Tuesday, June 18th 2019 at 2:00pm UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Microbiome Insights, Inc., a leading provider of microbiome DNA sequencing and bioinformatic analysis, today announced the appointment of Mr. Don Enns as an independent member to its Board of Directors. Enns has been a senior executive and leader in …
Plus »Zymeworks Files Preliminary Prospectus Supplements for Offering of Common Shares and Pre-Funded Warrants
Tuesday, June 18th 2019 at 8:05pm UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, has today filed a preliminary prospectus supplement (the “Canadian Supplement”) to its Canadian short form base shelf prospectus dated March 6, 2019 (the “Base Prospectus”) in connection with …
Plus »Specialized Life Sciences Job Board Now Available in Quebec Thanks to BioTalent Canada and BIOQuébec
Wednesday, June 19th 2019 at 12:00pm UTC MONTREAL–(BUSINESS WIRE)– BIOQuébec and BioTalent Canada have announced a collaboration agreement to facilitate access to human resources services specific to life sciences and biotech for all Quebec companies working in that sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190619005085/en/ …
Plus »LA PLATE-FORME DE MAIN-D’ŒUVRE SPÉCIALISÉE EN SCIENCES DE LA VIE MAINTENANT DISPONIBLE AU QUÉBEC GRÂCE À BIOTALENT CANADA ET BIOQUÉBEC
Wednesday, June 19th 2019 at 12:00pm UTC MONTRÉAL–(BUSINESS WIRE)– BIOQuébec et BioTalent Canada annoncent une entente de collaboration en vue de favoriser l’accès, à l’ensemble des entreprises du secteur des sciences de la vie et des biotechnologies du Québec, à des services de ressources humaines spécifiques au secteur. Ce communiqué …
Plus »
